» Articles » PMID: 16390332

Involvement of the Gi/o/cGMP/PKG Pathway in the AT2-mediated Inhibition of Outer Cortex Proximal Tubule Na+-ATPase by Ang-(1-7)

Overview
Journal Biochem J
Specialty Biochemistry
Date 2006 Jan 5
PMID 16390332
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanisms involved in the Ang-(1-7) [angiotensin-(1-7)] effect on sodium renal excretion remain to be determined. In a previous study, we showed that Ang-(1-7) has a biphasic effect on the proximal tubule Na+-ATPase activity, with the stimulatory effect mediated by the AT1 receptor. In the present study, we investigated the molecular mechanisms involved in the inhibition of the Na+-ATPase by Ang-(1-7). All experiments were carried out in the presence of 0.1 nM losartan to block the AT1 receptor-mediated stimulation. In this condition, Ang-(1-7) at 0.1 nM inhibited the Na+-ATPase activity of the proximal tubule by 54%. This effect was reversed by 10 nM PD123319, a specific antagonist of the AT2 receptor, and by 1 muM GDP[beta-S] (guanosine 5'-[beta-thio]diphosphate), an inhibitor of G protein. Ang-(1-7) at 0.1 M induced [35S]GTP[S] (guanosine 5'-[gamma-[35S]thio]triphosphate) binding and 1 mug/ml pertussis toxin, an inhibitor of G(i/o) protein, reversed the Ang-(1-7) effect. Furthermore, it was observed that the inhibitory effect of Ang-(1-7) on the Na+-ATPase activity was completely reversed by 0.1 microM LY83583, an inhibitor of guanylate cyclase, and by 2 muM KT5823, a PKG (protein kinase G) inhibitor, and was mimicked by 10 nM d-cGMP (dibutyryl cGMP). Ang-(1-7) increased the PKG activity by 152% and this effect was abolished by 10 nM PD123319 and 0.1 microM LY83583. Taken together, these data indicate that Ang-(1-7) inhibits the proximal tubule Na+-ATPase by interaction with the AT2 receptor that subsequently activates the G(i/o) protein/cGMP/PKG pathway.

Citing Articles

The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.

Steckelings U, Widdop R, Sturrock E, Lubbe L, Hussain T, Kaschina E Pharmacol Rev. 2022; 74(4):1051-1135.

PMID: 36180112 PMC: 9553111. DOI: 10.1124/pharmrev.120.000281.


Ceramide-1-Phosphate as a Potential Regulator of the Second Sodium Pump from Kidney Proximal Tubules by Triggering Distinct Protein Kinase Pathways in a Hierarchic Way.

Cabral L, Almeida F, Grelle G, Vieyra A, Caruso-Neves C, Einicker-Lamas M Curr Issues Mol Biol. 2022; 44(3):998-1011.

PMID: 35723289 PMC: 8947104. DOI: 10.3390/cimb44030066.


Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.

Fatima N, Patel S, Hussain T Hypertension. 2021; 77(6):1845-1856.

PMID: 33840201 PMC: 8115429. DOI: 10.1161/HYPERTENSIONAHA.120.11941.


Synergism between Angiotensin receptors ligands: Role of Angiotensin-(1-7) in modulating AT R agonist response on nitric oxide in kidney cells.

Patel S, Hussain T Pharmacol Res Perspect. 2020; 8(6):e00667.

PMID: 33197136 PMC: 7668194. DOI: 10.1002/prp2.667.


Angiotensin-(1-7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb.

Dibo P, Maranon R, Chandrashekar K, Mazzuferi F, Silva G, Juncos L Physiol Rep. 2019; 7(5):e14015.

PMID: 30839176 PMC: 6401662. DOI: 10.14814/phy2.14015.


References
1.
Matsubara M, Hayashi N, Jing T, Titani K . Regulation of endothelial nitric oxide synthase by protein kinase C. J Biochem. 2003; 133(6):773-81. DOI: 10.1093/jb/mvg099. View

2.
Markus R, Caruso-Neves C, Lopes A, Vieyra A . Adenosine inhibits the renal plasma-membrane (Ca2+ + Mg2+)-ATPase through a pathway sensitive to cholera toxin and sphingosine. Eur J Biochem. 1999; 263(1):71-8. DOI: 10.1046/j.1432-1327.1999.00456.x. View

3.
Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray J, Hasegawa M . Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991; 351(6323):230-3. DOI: 10.1038/351230a0. View

4.
Santos R, Campagnole-Santos M, Baracho N, Fontes M, Silva L, Neves L . Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull. 1994; 35(4):293-8. DOI: 10.1016/0361-9230(94)90104-x. View

5.
Kucharewicz I, Pawlak R, Matys T, Chabielska E, Buczko W . Angiotensin-(1-7): an active member of the renin-angiotensin system. J Physiol Pharmacol. 2003; 53(4 Pt 1):533-40. View